3D bioprinted mesenchymal stem cell laden scaffold enhances subcutaneous vascularization for delivery of cell therapy

Tommaso Bo,Elia Pascucci,Simone Capuani,Jocelyn Nikita Campa-Carranza,Letizia Franco,Marco Farina,Jacopo Secco,Sara Becchi,Rosanna Cavazzana,Ashley L. Joubert,Nathanael Hernandez,Corrine Ying Xuan Chua,Alessandro Grattoni

DOI: https://doi.org/10.1007/s10544-024-00713-2

2024-06-19

Biomedical Microdevices

Abstract:Subcutaneous delivery of cell therapy is an appealing minimally-invasive strategy for the treatment of various diseases. However, the subdermal site is poorly vascularized making it inadequate for supporting engraftment, viability, and function of exogenous cells. In this study, we developed a 3D bioprinted scaffold composed of alginate/gelatin (Alg/Gel) embedded with mesenchymal stem cells (MSCs) to enhance vascularization and tissue ingrowth in a subcutaneous microenvironment. We identified bio-ink crosslinking conditions that optimally recapitulated the mechanical properties of subcutaneous tissue. We achieved controlled degradation of the Alg/Gel scaffold synchronous with host tissue ingrowth and remodeling. Further, in a rat model, the Alg/Gel scaffold was superior to MSC-embedded Pluronic hydrogel in supporting tissue development and vascularization of a subcutaneous site. While the scaffold alone promoted vascular tissue formation, the inclusion of MSCs in the bio-ink further enhanced angiogenesis. Our findings highlight the use of simple cell-laden degradable bioprinted structures to generate a supportive microenvironment for cell delivery.

engineering, biomedical,nanoscience & nanotechnology

What problem does this paper attempt to address?

The main problem that this paper attempts to solve is to improve the efficacy of subcutaneous cell therapy. Specifically, the researchers developed a 3D - bioprinted scaffold made of alginate/gelatin (Alg/Gel) material and embedded with mesenchymal stem cells (MSCs), aiming to enhance vascularization and tissue growth in the subcutaneous microenvironment. Since the subcutaneous tissue has poor vascularization and it is difficult to support the implantation, survival and function of exogenous cells, this strategy is crucial for improving the effect of cell therapy.

### Research Background

1. **Application Prospects of Cell Therapy**:
- Cell therapy shows great potential in preventing and treating a variety of diseases, such as spinal cord injury, type 1 diabetes, Parkinson's disease, Alzheimer's disease, burns, stroke, cancer and osteoarthritis.
- The successful application of cell therapy requires a microenvironment that can support cell survival, growth, long - term function and integration with host tissues.

2. **Advantages and Challenges of the Subcutaneous Space**:
- The subcutaneous space is an ideal choice for cell therapy because it is easily accessible through minimally invasive surgery.
- However, the subcutaneous tissue has a low degree of vascularization, which poses a challenge to the high metabolic requirements and oxygen consumption of exogenous cells.

3. **Strategies for Enhancing Subcutaneous Vascularization**:
- Researchers have explored various methods to enhance the vascularization of the subcutaneous microenvironment, including local supply of pro - angiogenic factors (such as VEGF and FGF), use of platelet - rich plasma (PRP) hydrogels, and use of various materials to support the sustained release of pro - angiogenic factors.

### Research Objectives

- **Develop a 3D - bioprinted Scaffold**: This scaffold is made of alginate/gelatin (Alg/Gel) material and embedded with mesenchymal stem cells (MSCs) to enhance vascularization and tissue growth in the subcutaneous microenvironment.
- **Optimize the Mechanical Properties and Degradation Characteristics of the Scaffold**: By adjusting the cross - linking conditions, make the mechanical properties of the scaffold match those of the subcutaneous tissue and achieve controllable degradation in synchronization with the growth and remodeling of the host tissue.
- **Evaluate the In Vivo Effects of the Scaffold**: Conduct experiments in a rat model to evaluate the support of the scaffold for subcutaneous tissue development and vascularization.

### Main Findings

- **Mechanical Properties and Degradation Characteristics of the Scaffold**:
- A scaffold with appropriate mechanical properties and degradation characteristics was obtained through a cross - linking time of 5 minutes.
- Prolonging the cross - linking time will cause the scaffold to become too fragile and increase the risk of mechanical failure.

- **Cell Viability and Proliferation**:
- The cross - linking time of 5 minutes does not affect the viability of MSCs, while the cross - linking time of 24 hours will lead to cell death.
- The 3D - bioprinting process does not significantly affect the viability of MSCs, and there is no obvious difference compared with the traditional Pluronic hydrogel loading method.

- **In Vivo Effects**:
- In the rat model, the Alg/Gel scaffold is superior to the Pluronic hydrogel embedded with MSCs in supporting subcutaneous tissue development and vascularization.
- The scaffold alone can promote the formation of vascular tissue, and the scaffold embedded with MSCs further enhances angiogenesis.

### Conclusion

This study demonstrates the potential application value of the 3D - bioprinted Alg/Gel scaffold in subcutaneous cell therapy. By optimizing the mechanical properties and degradation characteristics of the scaffold and embedding MSCs, a microenvironment that supports cell survival and function can be created, thereby improving the effect of cell therapy.